BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2533618)

  • 1. Treatment of uterine leiomyomas and hirsutism with nafarelin.
    Monroe SE; Andreyko J
    J Reprod Med; 1989 Dec; 34(12 Suppl):1029-33. PubMed ID: 2533618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging.
    Andreyko JL; Blumenfeld Z; Marshall LA; Monroe SE; Hricak H; Jaffe RB
    Am J Obstet Gynecol; 1988 Apr; 158(4):903-10. PubMed ID: 2966587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal therapy before surgical treatment for uterine leiomyomas.
    Moghissi KS
    Surg Gynecol Obstet; 1991 Jun; 172(6):497-502. PubMed ID: 1827931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of uterine fibroids: current findings with gonadotropin-releasing hormone agonists.
    Adamson GD
    Am J Obstet Gynecol; 1992 Feb; 166(2):746-51. PubMed ID: 1531577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical use of nafarelin in the treatment of leiomyomas. A review of the literature.
    Minaguchi H; Wong JM; Snabes MC
    J Reprod Med; 2000 Jun; 45(6):481-9. PubMed ID: 10900582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of nafarelin to investigate the pathophysiology of the polycystic ovary syndrome.
    Shaw RW
    J Reprod Med; 1989 Dec; 34(12 Suppl):1039-43. PubMed ID: 2533620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hirsutism with a gonadotropin-releasing hormone agonist (nafarelin).
    Andreyko JL; Monroe SE; Jaffe RB
    J Clin Endocrinol Metab; 1986 Oct; 63(4):854-9. PubMed ID: 2943756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shrinkage effect of gonadotropin releasing hormone agonist treatment on uterine leiomyomas and t(12;14).
    Takahashi K; Kawamura N; Ishiko O; Ogita S
    Int J Oncol; 2002 Feb; 20(2):279-83. PubMed ID: 11788889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservative management for perimenopausal women with uterine leiomyomas using Chinese herbal medicines and synthetic analogs of gonadotropin-releasing hormone.
    Sakamoto S; Mitamura T; Iwasawa M; Kitsunai H; Shindou K; Yagishita Y; Zhou YF; Sassa S
    In Vivo; 1998; 12(3):333-7. PubMed ID: 9706480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of LHRH analogue action in uterine fibroids.
    Shaw RW
    Horm Res; 1989; 32 Suppl 1():150-3. PubMed ID: 2533145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The GnRH agonists in the treatment of uterine leiomyomas.
    Bianchi S; Fedele L
    Acta Eur Fertil; 1989; 20(1):5-10. PubMed ID: 2675524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of insuflated Nafarelin (D-Nal-6-GnRH) upon uterine leiomyomata.
    Ayala AR; Meza E; Cervera Aguilar R; Hernández Marín I
    Arch Med Res; 1995; 26 Spec No():S23-6. PubMed ID: 8845654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gonadotropin-releasing hormone analogs].
    Krysiak R; Okopień B; Herman ZS
    Pol Merkur Lekarski; 2005 May; 18(107):585-9. PubMed ID: 16161962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nafarelin on uterine fibroids measured by ultrasound and magnetic resonance imaging.
    Williams IA; Shaw RW
    Eur J Obstet Gynecol Reprod Biol; 1990; 34(1-2):111-7. PubMed ID: 2137421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Short-term therapy of uterine fibromyomatosis with GN-Rh analog].
    Massacesi M; Milkowski M; Gianfranceschi C; Massacesi L
    Minerva Ginecol; 1992 Dec; 44(12):641-4. PubMed ID: 1491772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effect of gonadotropin-releasing hormone analog (Diphereline) and Cabergoline (Dostinex) treatment on uterine myoma regression.
    Melli MS; Farzadi L; Madarek EO
    Saudi Med J; 2007 Mar; 28(3):445-50. PubMed ID: 17334477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical applications of gonadotropin-releasing hormones in reproductive disorders.
    Moghissi KS
    Endocrinol Metab Clin North Am; 1992 Mar; 21(1):125-40. PubMed ID: 1576979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
    Magalhães J; Aldrighi JM; de Lima GR
    Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic uses of gonadotropin-releasing hormone analogs.
    Andreyko JL; Marshall LA; Dumesic DA; Jaffe RB
    Obstet Gynecol Surv; 1987 Jan; 42(1):1-21. PubMed ID: 3543765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of GnGH (GnRH-A) in gynecology].
    Ciardo A; Spina V; Aleandri V
    Minerva Ginecol; 1998; 50(1-2):25-9. PubMed ID: 9577152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.